Gemcitabine Injection 38 mg (Gemcitabine (Gemcitabine Hydrochloride) SOLUTION) 38 MG

Gemcitabine Injection 38 mg is a cancer treatment medication used to slow or stop cancer cell growth. This intravenous solution is manufactured by Pfizer Canada ULC and is available in 5.3/26.3/52.6 mL pack sizes.

Strength

38 MG

Pack Size

5.3/26.3/52.6ML

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gemcitabine Injection 38 mg is primarily used in the treatment of various types of cancer. It works by interfering with the growth and spread of cancer cells in the body. This medication is often prescribed for conditions such as pancreatic cancer, non-small cell lung cancer, and breast cancer. Patients may wonder, 'What is Gemcitabine used for?' and the answer is that it is a chemotherapy agent designed to target and destroy rapidly dividing cancer cells.

Side Effects

Common effects of Gemcitabine Injection 38 mg may include fatigue, nausea, and vomiting. Some patients may experience a decrease in blood cell counts, which can lead to an increased risk of infection or bleeding. It is important to monitor for any unusual symptoms and consult a healthcare provider if severe side effects occur.

Precautions & Warnings

Gemcitabine Injection 38 mg should be handled with care and administered by a healthcare professional. It is important to follow all safety guidelines when using this medication. Patients should inform their healthcare provider about any allergies or pre-existing conditions before starting treatment. Proper storage and disposal of the medication are crucial to ensure safety.

Avoid Interactions

Gemcitabine Injection 38 mg may interact with other medications, including certain antibiotics and medications that affect the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that suppress the immune system should be avoided during treatment.

Frequently Asked Questions

Gemcitabine Injection 38 mg is used in the treatment of various types of cancer, including pancreatic cancer, non-small cell lung cancer, and breast cancer.

Gemcitabine Injection 38 mg is administered intravenously by a healthcare professional in a clinical setting.

Common side effects may include fatigue, nausea, vomiting, and a decrease in blood cell counts.

Gemcitabine Injection 38 mg may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Gemcitabine Injection 38 mg should be stored according to the manufacturer's guidelines to maintain its effectiveness and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.